I basically continued eating the same amount while on the meds and ended up with less money, more nausea, and a worse self-image than what I started with
About 1 in 8 Americans uses GLP-1 drugs for diabetes, weight loss and other chronic conditions, including semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
The studies showed that survodutide therapy led to a maximum placebo-corrected body weight loss of 13.8% by week 16, demonstrating its potential for significant weight loss [110]
However, the treatment is not without challenges, and it can lead to side effects like fatigue, slower metabolism, and brain fog
Monitoring and titration If you are microdosing GLP-1 medications, it is important to track the side effects carefully, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation